Anchor-based classification and type-C inhibitors for tyrosine kinases-Reference-Cited by-同舟云学术

Anchor-based classification and type-C inhibitors for tyrosine kinases

Published:2015-06-16 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Hsu Kai-Cheng,Sung Tzu-Ying,Lin Chih-Ta,Chiu Yi-Yuan,Hsu John T.-A.,Hung Hui-Chen,Sun Chung-Ming,Barve Indrajeet,Chen Wen-Liang,Huang Wen-Chien,Huang Chin-Ting,Chen Chun-Hwa,Yang Jinn-Moon

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep10938.pdf

Reference47 articles.

1. Endicott, J. A., Noble, M. E. M. & Johnson, L. N. The Structural Basis for Control of Eukaryotic Protein Kinases. Annu. Rev. Biochem. 81, 587–613 (2012).

2. Levitzki, A. Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity and Clinical Performance. Annu. Rev. Pharmacol. Toxicol. 53, 161–185 (2013).

3. Krause, D. S. & Van Etten, R. A. Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med. 353, 172–187 (2005).

4. Gocek, E., Moulas, A. N. & Studzinski, G. P. Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells. Crit. Rev. Clin. Lab. Sci. 51, 125–137 (2014).

5. Liao, J. J. L. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J. Med. Chem. 50, 409–424 (2007).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma;Frontiers in Pharmacology;2023-05-24

2. Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer;Biomolecules;2022-10-02

3. Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations;Archiv der Pharmazie;2021-08-19

4. A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation;Journal of Medicinal Chemistry;2020-11-20

5. A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors;Scientific Reports;2020-06-29